DP
REPL icon

Diadema Partners’s Replimune Group REPL Stock Holding History

Diadema Partners’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.71M Buy
696,300
+490,800
+239% +$3M 0.97% 30
2026
Q1 		$1.57M Buy
+205,500
New +$1.57M 0.27% 71
2025
Q4 		– Sell
-612,300
Closed -$2.57M – 185
2025
Q3 		$2.57M Buy
+612,300
New +$3.91M 0.66% 52

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Diadema Partners's REPL Position: Q2 2026 in Review

Diadema Partners sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 100,660 shares — an estimated $616K sold.

Diadema Partners first reported a position in REPL in Q4 2024 and held it in 5 quarters. The position peaked at $2.25M in Q4 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Diadema Partners reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
  • Diadema Partners sold 100,660 Replimune Group shares in Q2 2026, an estimated $616K.
  • Diadema Partners first reported a position in Replimune Group in Q4 2024 and held it in 5 quarters.
  • Diadema Partners's Replimune Group position peaked at $2.25M in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.